Theralase Technologies Inc. holds Annual General and Special Meeting on June 19th in Toronto, with virtual attendance via Zoom.

Theralase Technologies Inc., a clinical-stage pharmaceutical company focused on light and/or radiation-activated small molecules for cancer, bacteria, and virus treatments, reminds shareholders of its Annual General and Special Meeting (AGSM) on June 19th at 4:30 pm ET in Toronto. Virtual attendance via Zoom is available from 5:30-6:30 pm ET, featuring a corporate presentation and Q&A session. An archived version will be accessible on Theralase's website.